Stay updated with breaking news from Gallium Maltolate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IQ-AI Limited subsidiary Imaging Biometrics has announced a series of developments, including regulatory achievements, advancements in current applications,...
The FDA has granted an orphan drug designation to gallium maltolate for use as a potential therapeutic option in pediatric patients with glioblastoma multiforme.
IQ-AI Ltd - Jersey-based medical services firm - Says subsidiary Imaging Biometrics LLC's two new pre-clinical studies show oral Gallium Maltolate inhibits brain tumour growth in children. Says the results are consistent with previous work conducted in ...
Investegate announcements from IQ-AI Limited, Orphan Drug Designation Status
Investegate announcements from IQ-AI Limited, Final Results